MarketFriction

Rainbow Childrens Medicare Ltd

NSE RAINBOW · BSE 543524 · Hospital
₹1,279.80 -2.62%
NSE close2026-10-01
52 week range1,084.00 - 1,610.00
Market cap₹13,892 Cr.
P/E48.5
IPO 2022 · +136% since Nifty 500Smallcap 250 Price band 20% Delivery 61.1%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales333336341330417398370353445445460470
Expenses215218236236270264255249296298315335
Operating Profit11811810694147134115104149147145135
OPM %35%35%31%28%35%34%31%29%33%33%31%29%
Other Income89131211131520811413
Interest131417181818181819202021
Depreciation272832343535343436404142
Profit before tax85856953105947771102988784
Tax %26%26%26%26%25%27%27%25%26%24%10%26%
Net Profit636351407969575476747863
EPS in Rs6.206.125.023.897.776.765.555.277.417.147.595.96
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2343214025437196509741,1741,2971,5161,7031,820
Expenses2042663323915194856667748651,0221,1551,245
Operating Profit305569151201165308400432494548575
OPM %13%17%17%28%28%25%32%34%33%33%32%32%
Other Income16111081010193137514235
Interest334424846565863778281
Depreciation1822286069738390112138151159
Profit before tax244147589356187282295330358371
Tax %28%24%22%22%41%29%26%25%26%26%21%
Net Profit173136455540139212218244282290
EPS in Rs18.2233.788.2510.1412.689.1014.7020.7721.3823.9727.4028.10
Dividend Payout %11%7%12%10%16%0%14%14%14%13%13%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth22%21%13%18%
Compounded Profit Growth31%44%6%11%
Stock Price CAGR%%10%1%
Return on Equity17%19%17%16%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9994444444494102102102102
Reserves1662753083073173503914989581,1571,3671,547
Borrowings22242624476501529592570765764891
Other Liabilities3441557389123116112140146145236
Total Liabilities2313493994489261,0191,0811,2961,7712,1702,3772,775
Fixed Assets781231742967027027728589311,2531,3981,756
CWIP3531712234329623202879
Investments7260310182258308571404
Other Assets111194212140199265262409759590380535
Total Assets2313493994489261,0191,0811,2961,7712,1702,3772,775
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity26173648127170143224329321396420
Cash from Investing Activity-20-107-33-42-117-117-83-175-465-226-268-259
Cash from Financing Activity-793-1-7-9-52-61-44143-102-118-147
Net Cash Flow-131-222-147-71014
Free Cash Flow-35-46-21-103429667162188-32250204
CFO/OP95%88%79%88%94%95%102%93%103%95%97%95%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days111016142422251516201922
Inventory Days393548363255362843535267
Days Payable121107142151197202190121182180170162
Cash Conversion Cycle-72-62-79-100-141-124-130-78-123-107-100-73
Working Capital Days-35-36-28-31-26-18-17-167343198
ROCE %22%11%14%14%16%16%11%23%24%19%19%17%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters49.83%49.83%49.83%49.87%49.85%49.85%49.85%49.85%49.85%49.84%49.84%49.84%
FIIs21.63%22.32%24.04%24.78%25.12%25.12%23.69%23.60%21.85%19.24%17.24%16.03%
DIIs15.39%15.62%14.76%13.81%13.84%13.87%15.31%15.44%17.46%19.49%21.12%22.56%
Public13.14%12.23%11.37%11.53%11.20%11.16%11.14%11.11%10.82%11.40%11.68%11.39%
Others0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.04%0.12%0.18%
No. of Shareholders79,18780,47177,15278,55777,52478,76479,09280,32081,13488,80988,56189,305

Fundamentals

Market Cap₹ 13,892 Cr.
Current Price₹ 1,368
Stock P/E48.5
Book Value₹ 162
ROCE17.4 %
ROE15.9 %
Dividend Yield0.26 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)11%
Consolidated figures.
Valuation
Market capRs 12,998 Cr
Enterprise valueRs 13,855 Cr
P/E (TTM)45.54x
Price to book7.89x
Price to sales7.14x
EV / EBITDA22.71x
EV / EBIT30.68x
EV / sales7.61x
Price to cash flow30.97x
Earnings yield2.20%
Dividend yield0.27%
P/E, 3-year average53.87x
P/B, 3-year average9.11x
P/E, 5-year average49.20x
P/B, 5-year average8.58x
Profitability
Operating margin (excl. other income)32.20%
Operating margin (incl. other income)34.68%
EBITDA margin33.52%
Pre-tax margin20.37%
Net profit margin15.68%
Net margin, latest quarter12.89%
ROE17.86%
ROCE18.45%
ROA10.80%
ROE, 3-year average18.14%
ROCE, 3-year average19.04%
ROA, 3-year average10.84%
ROE, 5-year average21.38%
ROCE, 5-year average20.79%
ROA, 5-year average11.58%
ROIC (approx.)14.17%
Tax rate21.41%
Other income / net worth2.56%
Growth
Sales growth (latest year)12.35%
Profit growth (latest year)14.34%
Sales CAGR, 3 years13.22%
Sales CAGR, 5 years21.24%
Profit CAGR, 3 years9.70%
Profit CAGR, 5 years47.39%
Sales growth QoQ2.19%
Profit growth QoQ-21.38%
Sales growth YoY (latest quarter)33.17%
Profit growth YoY (latest quarter)13.21%
Per share
EPS (TTM)Rs 28.10
EPS (latest year)Rs 27.40
EPS (latest quarter)Rs 5.96
EPS, 3-year averageRs 24.25
EPS, 5-year averageRs 21.65
Book value per shareRs 162.28
Sales per shareRs 179.22
Cash flow per shareRs 41.32
Free cash flow per shareRs 20.09
Dividend per share (latest year)Rs 3.50
Dividend per share, 3-year averageRs 3.17
Dividend per share, 5-year averageRs 2.90
Dividends
Dividend payout12.77%
Dividend payout, 3-year average13.11%
Dividend payout, 5-year average13.47%
Efficiency
Asset turnover0.61x
Fixed asset turnover0.97x
Inventory turnover9.18x
Inventory days40 days
Debtor days22 days
Debtors turnover16.51x
Creditor days162 days
Cash conversion cycle-73 days
Working capital days8 days
Leverage
Total debtRs 891 Cr
Cash and bankRs 34 Cr
Net debtRs 857 Cr
Debt to equity0.54x
Net debt / EBITDA1.40x
Interest coverage5.59x
Current ratio (filing 2026-03-31)3.59x
Quick ratio (filing 2026-03-31)3.37x
Trade payables (filing 2026-03-31)Rs 101 Cr
Owners' fund to total sources59.39%
Debt to assets32.11%
Cash flow
Cash from Operating Activity (latest year)Rs 420 Cr
Cash from Investing Activity (latest year)Rs -259 Cr
Cash from Financing Activity (latest year)Rs -147 Cr
Net Cash Flow (latest year)Rs 14 Cr
Free cash flow (latest year)Rs 204 Cr
FCFE (approx.: FCF + change in debt)Rs 331 Cr
Cash from ops / profit, 5 years1.54x
Sales to cash flow4.06x
Statement figures
Net sales (TTM)Rs 1,820 Cr
Net sales (latest year)Rs 1,703 Cr
Sales (latest quarter)Rs 470 Cr
Operating profit excl. other income (latest year)Rs 548 Cr
Operating profit (latest quarter)Rs 135 Cr
Other income (TTM)Rs 35 Cr
EBITDA (TTM)Rs 610 Cr
PBDT (TTM)Rs 529 Cr
Profit before tax (TTM)Rs 371 Cr
Tax (latest year)Rs 77 Cr
Net profit (TTM)Rs 285 Cr
Net profit (latest year)Rs 278 Cr
Net profit (latest quarter)Rs 61 Cr
Depreciation (TTM)Rs 159 Cr
Depreciation (latest quarter)Rs 42 Cr
Interest (TTM)Rs 81 Cr
Cost of goods sold (latest year)Rs 382 Cr
Total expenditure (latest year)Rs 1,155 Cr
Total income (latest year)Rs 1,745 Cr
Share capitalRs 102 Cr
ReservesRs 1,547 Cr
Shareholders' fundsRs 1,648 Cr
Total assetsRs 2,775 Cr
Net blockRs 1,756 Cr
Capital work in progressRs 79 Cr
InvestmentsRs 404 Cr
ReceivablesRs 103 Cr
InventoryRs 42 Cr
Other liabilitiesRs 236 Cr
Shares outstanding (crore)10.16
Ownership
Promoter holding49.84% (-0.01 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 45.5 is at the 6th percentile of its own 4.5-year range (median 54.3, low 34.2, high 126.2).
P/B 7.89 is at the 2th percentile (median 10.48).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodRAINBOWNifty 50Difference
1 week-9.4%-2.8% -6.6 pts
1 month-11.5%-6.8% -4.7 pts
3 months-11.1%-7.6% -3.5 pts
6 months+10.0%+0.4% +9.6 pts
1 year-7.6%-9.9% +2.3 pts
2 years-6.4%-13.6% +7.1 pts
3 years+24.5%+14.2% +10.3 pts
103 mutual fund schemes hold about ₹2,835 Cr. Over three months 76 bought more and 9 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
ICICI Pru Large & Mid Cap Fund1.03%346 +4%
DSP Small Cap Fund1.00%217 +2%
Motilal Oswal Small Cap Fund2.40%196 +11%
ICICI Pru Multi Asset Allocation Fund0.22%191 +9%
Axis Small Cap Fund0.48%150 +5%
DSP Flexi Cap Fund1.08%135 +10%
Nippon India Small Cap Fund0.13%111 +7%
DSP Aggressive Hybrid Fund0.93%109 -13%
ICICI Pru Healthcare Fund-1.36%95 +7%
DSP India T.I.G.E.R Fund1.43%93 +9%
ICICI Pru Multi Cap Fund0.47%93 +5%
ICICI Pru Multi Cap Fund0.47%89 +5%
Tata ELSS-Tax Saver Fund1.60%76 +9%
Tata India Pharma & Healthcare Fund4.47%69 +14%
Tata Retirement Sav Fund - Prog Plan2.15%48 +8%
Bandhan Flexi Cap Fund0.58%44 +11%
SBI Healthcare Opp Fund0.73%42 -3%
Abakkus Small Cap Fund1.45%40 -2%
Tata Retirement Sav Fund - Mod Plan1.75%39 +9%
ICICI Pru Bharat Consumption Fund1.13%37 +10%
Axis Multicap Fund0.33%37 -2%
UTI Healthcare Fund2.25%33 +23%
Nippon India Innovation Fund1.01%31 +6%
UTI Multi Cap Fund1.43%31 +16%
Kotak Balanced Advantage Fund0.18%31 +13%

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹470 Cr +33.1% vs Jun 2025. Net profit ₹63 Cr +16.7%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-21Dividend - Rs 3.50 Per Share
2025-06-27Dividend - Rs 3 Per Share
2024-07-23Annual General Meeting/Dividend - Rs 3 Per Share
2023-06-22Annual General Meeting/Dividend - Rs 3 Per Share
2022-09-07Annual General Meeting/Dividend - Rs 2 Per Share
DateTypeWhat it says
2026-09-30UpdatesExecution of lease agreement with APCRDA for development of a children s hospital at Amravati, Andhra Pradesh.
2026-09-29Credit RatingCredit Rating
2026-09-23AppointmentAppointment of Mr Sudarshan Patodia as Chief Financial Officer of the company w.e.f. September 23, 2026.
2026-09-23ESOP grantThe grant of options
2026-09-23UpdatesIntimation of Contact Details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) Regulations, 2015.
2026-09-23Board meeting outcomeOutcome of Board Meeting held on September 23, 2026.
2026-09-16General UpdatesCommencement of operations at Guntur, Andhra Pradesh.
2026-09-11Concall / analyst meetSchedule of meet of Analyst/Institutional Investors Group Meetings.
2026-08-31ResignationResignation of Director/KMP/SMP
2026-08-31ResignationResignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026.
2026-08-25ResignationResignation of Director/KMP/SMP
2026-08-25ResignationResignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026.
2026-08-14General UpdatesUpdate on Acquisition.
2026-08-04Concall / analyst meetTranscript
2026-07-31Concall / analyst meetLink of Recording
2026-07-30Press ReleaseA press release dated July 30, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30...
2026-07-30Concall / analyst meetPresentation
2026-07-30Investor PresentationInvestor Presentation
2026-07-30ESOP grantThe grant of options
2026-07-30AppointmentAppointment of Mr Anshuman Jaiswal as senior management personnel of the company w.e.f. July 30, 2026.
2026-07-30Board meeting outcomeOutcome of Board Meeting held on July 30, 2026.
2026-07-30Board meeting outcomeRainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.
2026-07-29Capacity additionCapacity addition
2026-07-29Capacity additionCapacity addition
2026-07-29AcquisitionAcquisition
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Rainbow Childrens Medicare Ltd?

Rainbow Childrens Medicare Ltd (RAINBOW) has a market capitalisation of Rs 13,892 Cr. at the 2026-10-01 close.

What is the P/E ratio of Rainbow Childrens Medicare Ltd?

Rainbow Childrens Medicare Ltd trades at a P/E of 48.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were Rainbow Childrens Medicare Ltd's latest quarterly results?

In the Jun 2026 quarter, Rainbow Childrens Medicare Ltd sales was Rs 470 Cr (+33.1% vs Jun 2025) and net profit was Rs 63 Cr.

What is the 52-week high and low of Rainbow Childrens Medicare Ltd?

The 52-week high is Rs 1,610.00 and the 52-week low is Rs 1,084.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03